Pharmacy Practice & Development

Critical Care Pharmacy Handbook 2nd Edition

Date: 15 October 2023 - 5:20am

This 2nd edition of the Critical Care Pharmacy Handbook has sections and topics which have been revised for easy and handy reading, highlighting common issues in critical care pharmacotherapy for the pharmacists.

English

GARIS PANDUAN SISTEM PENGURUSAN PEMBEKALAN UBAT BAGI PERKHIDMATAN NILAI TAMBAH FARMASI (MyUBAT)

Date: 27 April 2021 - 10:33am

In line with the current technology development, Pharmacy Practice & Development Division and Pharmacy Policy & Strategic Planning Division have collaborated and developed “Sistem Pengurusan Pembekalan Ubat Bagi Perkhidmatan Nilai Tambah Farmasi (MyUBAT)” in which facilitate patients in managing and monitoring their medicine supply via smart phone. Besides, this system can assist the pharmacists’ working process in the pharmacy counter, including the registration dan preparation of the medicine supply.

English

Guideline on Safe Use of High Alert Medications (HAMs) Second Edition

Date: 11 February 2021 - 10:15am

High Alert Medications (HAMs) are medications that bear a heightened risk of causing significant patient harm when these medications are used in error.

This guideline outlines the safe use of high alert medications and recommends the risk prevention strategies that can be implemented by health care providers on the management of high alert medications at all stages. 

English

Guidance On The Requirement To Import, Handle, Store And Distribute COVID-19 Vaccines In Malaysia

Date: 15 January 2021 - 10:31am

The purpose of this document is to provide guidance on the requirement to import, handle, store and distribute COVID-19 vaccines in Malaysia to ensure quality, safety dan efficacy of the products are preserved until the point of vaccina

English

Unified Public Consultation (UPC): Implementation of Medicines Price Mechanism & Cost-Benefit Analysis

We are pleased to inform that the Pharmaceutical Services Program, Ministry of Health Malaysia (MOH) is ​currently ​holding multiple online briefing session on the latest status of Medicines Price Mechanism and Cost-Benefit Analysis (CBA) estimating the impact of implementing Medicines Price Mechanism to the stakeholders​.

The session is being conducted​ from January 4 and end on January 6, 2021. Following​ that, you are invited to provide further feedback based on the information shared during the briefing session, through the Unified Public Consultation; the link as follows: 

Location/place: 
Online: Unified Public Consultation (UPC)
Date: 
Tuesday, 5 January 2021 to Monday, 25 January 2021

Protocol Medication Therapy Adherence Clinic-Cardiac Rehabilitation (CR-MTAC) 1ST Edition (Year 2020)

Date: 21 December 2020 - 7:48pm

The CR-MTAC protocol aims to  assist pharmacists in initiating and conducting the activities of cardiac rehabilitation in a standardized manner across all Ministry of Health’s (MOH) hospitals/clinics.  It contains workflow of standard operating procedures and documentations that are needed to conduct CR-MTAC. 

English

Anticoagulation MTAC (AC-MTAC) Protocol 2nd Edition

Date: 21 December 2020 - 7:17pm

Anticoagulation Medication Therapy Adherence Clinic (AC-MTAC) was formerly known as Warfarin MTAC (WMTAC). Due to the discovery of direct oral anticoagulants (DOACs) such as Dabigatran, Rivaroxaban dan Apixaban in recent years, this has prompted the Clinical Pharmacy Working Committee (Cardiology Subspecialty) to revise and come up with AC-MTAC Protocol.

English

The Report on Antibiotic Utilisation in Malaysian Hospitals 2008-2017

Date: 18 December 2020 - 10:29am

The surveillance on antibiotic utilisation is conducted at selected hospitals nationwide which include Ministry of Health hospitals, university hospitals, military hospitals and private hospitals.

English

Pages